Hepatitis C virus asialoglycoproteins

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 5, 4241851, 4242281, 530395, 530826, C12Q 170, C12P 2104, A61K 3929

Patent

active

060748524

ABSTRACT:
Two Hepatitis C Virus envelope proteins (E1 and E2) are expressed without sialylation. Recombinant expression of these proteins in lower eukaryotes, or in mammalian cells in which terminal glycosylation is blocked, results in recombinant proteins which are more similar to native HCV glycoproteins. When isolated by GNA lectin affinity, the E1 and E2 proteins aggregate into virus-like particles.

REFERENCES:
patent: 5350571 (1994-09-01), Houghton et al.
Rudolph et al., "The Yeast Secretory Pathway . . . ," Cell 58:133-145 (1989).
Sleep et al., "The Secretion of Human Serum . . . ," Bio/Techology 8: 42-46 (1990).
Goochu et al., "The Oligosaccharides of Glycoproteins:," Bio/Technology 9: 1347-1355 (1991).
Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technololgy, p. 138 (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hepatitis C virus asialoglycoproteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis C virus asialoglycoproteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus asialoglycoproteins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2067546

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.